Compare ImmunityBio Inc. Common Stock (IBRX) vs JPMorgan Diversified Return International Eqty ETF (JPIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs JPMorgan Diversified Return International Eqty ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.25 (market cap $10.51B), while JPMorgan Diversified Return International Eqty ETF trades at $73.01 (market cap $378.77M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 27.7× JPMorgan Diversified Return International Eqty ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, JPMorgan Diversified Return International Eqty ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and JPMorgan Diversified Return International Eqty ETF for 120 Days on average.
| IBRX | JPIN | |
|---|---|---|
Market Cap | $10.51B | $378.77M |
Volume | 10,445,785 | 13,861 |
Sector | Health | — |
52-Week High | $11.55 | $77.80 |
52-Week Low | $1.98 | $64.96 |
Typical Hold Time | 0 Days | 120 Days |
Enterprise Value | $10.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPIN trades at $73.01, showing minimal daily movement with a 0.1% gain. Technical indicators are predominantly bearish, with moving averages and oscillators signaling selling pressure, though RSI levels suggest potential oversold conditions. The ETF, designed for international equity exposure, lacks current fundamental data for valuation ratios and profitability metrics.
The outlook remains cautious due to strong bearish technical signals and absence of recent financial updates. Key risks include market volatility and reliance on international equities. Investors should await earnings reports for fundamental clarity, as current data is insufficient to assess valuation or growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →
